NXL

Nexalin Technology, Inc. · NASDAQ

Sector Health Technology
Industry Medical Specialties
Website nexalin.com
Employees(FY) 6
ISIN US65345B2016

Performance

-36.78%

-32.22%

+275.45%

+152.88%

+549.7%

YTD

+806.9%

Profile

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. In addition, it designs and develops Generation 2 and Generation 3, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, Alzheimer's disease, and dementia. The company is based in Houston, Texas.

Advanced Technical Analysis

Technical Analysis of NXL 2024-12-20

The stock indicators reflect a bearish sentiment overall, with the Moving Average Score at 30, Oscillators Score at 40, and a Technical Score of 35, indicating weakness in momentum and trend direction. This combination suggests caution for potential investors, as the scores collectively point towards a lack of bullish momentum in the market.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of NXL

Stock Rank

Recent News & Updates

2024-11-25 21:00
New Peer-Reviewed Publication Validates Nexalin's Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market(Globenewswire)
2024-11-10 19:00
Nexalin Technology CEO Provides Letter to Shareholders(Globenewswire)
2024-11-01 02:00
Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on November 5th(Globenewswire)
2024-10-31 22:34
Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements(Globenewswire)
2024-10-31 21:00
LOBO EV and Nexalin Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV(Accesswire)
2024-10-27 20:30
Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's Disease(Globenewswire)
2024-10-24 21:00
Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV(Accesswire)
2024-10-22 02:15
Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VA(Globenewswire)
2024-10-16 20:30
New Study Shows Nexalin's Deep Intracranial Frequency Stimulation (DIFS) Significantly Improves Memory and Cognitive Function in Alzheimer's Patients(Globenewswire)
2024-10-13 20:30
Nexalin Technology Appoints Carolyn Shelton as Senior Vice President of Clinical, Quality & Regulatory Affairs(Globenewswire)
2024-09-04 21:00
Nexalin Technology Participates in Congressional Roundtable Focused on Emerging Virtual Therapeutic Options for Opioid Treatment(Globenewswire)
2024-07-25 21:55
Nexalin Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV(Accesswire)
2024-07-17 20:30
Nexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use Recovery(Globenewswire)
2024-07-01 02:45
Nexalin Technology Announces Closing of $5.2 Million Public Offering(Globenewswire)
2024-06-30 18:31
The 3 Smartest Penny Stocks to Buy With Your Money Right Now(Investorplace)
2024-06-27 20:31
Why Is Nexalin Technology (NXL) Stock Down 35% Today?(Investorplace)
2024-06-27 19:39
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday(Investorplace)
2024-06-27 09:15
Nexalin Technology Announces Pricing of $5.2 Million Public Offering(Globenewswire)
2024-06-25 21:00
Nexalin Technology Announces Positive Clinical Study Data in Major Depressive Disorder and Publication of Clinical Trial Results in Leading Scientific Journal(Globenewswire)
2024-06-19 20:30
Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Alzheimer's and Dementia(Globenewswire)
2024-06-19 19:28
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday(Investorplace)
2024-06-13 21:00
Nexalin Technology and VolitionRX Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV(Accesswire)
2024-06-13 20:21
Why Is Nexalin Technology (NXL) Stock Down 29% Today?(Investorplace)
2024-06-13 19:30
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday(Investorplace)
2024-06-13 03:00
Nexalin Technology Announces Regulatory Approval to Sell Nexalin's Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa)(Globenewswire)
2024-06-05 19:00
MicroCap Rodeo's Spring into Summer Conference, June 6th 2024 - 25 Presenting Companies(Accesswire)
2024-06-03 20:30
Nexalin Technology to Present at the Spring MicroCap Rodeo Conference on June 6th(Globenewswire)
2024-06-02 20:30
FDA Provides Feedback and Reaches Consensus on Nexalin's Design for Planned Anxiety and Insomnia Clinical Studies of its Gen-3 HALO Clarity Headset Device(Globenewswire)
2024-05-29 19:47
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday(Investorplace)
2024-05-21 20:30
Nexalin America Selected to Join the National Traumatic Brain Injury Registry Coalition to Propel TBI Awareness and Research Efforts(Globenewswire)

Page 1 of 3

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.